1.63
price up icon3.88%   0.08
 
loading
전일 마감가:
$1.55
열려 있는:
$1.55
하루 거래량:
40,955
Relative Volume:
0.64
시가총액:
$59.67M
수익:
$134.00K
순이익/손실:
$-9.93M
주가수익비율:
-4.4054
EPS:
-0.37
순현금흐름:
$-6.72M
1주 성능:
-9.54%
1개월 성능:
-12.97%
6개월 성능:
-32.63%
1년 성능:
+120.56%
1일 변동 폭
Value
$1.5373
$1.69
1주일 범위
Value
$1.5373
$1.79
52주 변동 폭
Value
$0.52
$3.35

Entera Bio Ltd Stock (ENTX) Company Profile

Name
명칭
Entera Bio Ltd
Name
전화
972-2-532-7151
Name
주소
KIRYAT HADASSAH, MINRAV BUILDING, JERUSALEM
Name
직원
20
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
ENTX's Discussions on Twitter

ENTX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
ENTX 1.63 59.67M 134.00K -9.93M -6.72M -0.37
VRTX 450.10 115.43B 10.63B -479.80M -1.35B 13.33
REGN 745.44 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 595.64 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.18 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 108.06 24.89B 3.30B -501.07M 1.03B 11.54

Entera Bio Ltd Stock (ENTX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-03-22 개시 Aegis Capital Buy

Entera Bio Ltd 주식(ENTX)의 최신 뉴스

pulisher
Nov 20, 2024

Knoll Capital Management, LLC's Strategic Acquisition in Entera Bio Ltd - GuruFocus.com

Nov 20, 2024
pulisher
Nov 17, 2024

Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Update - MarketBeat

Nov 17, 2024
pulisher
Nov 14, 2024

FY2024 EPS Estimate for Entera Bio Decreased by Analyst - MarketBeat

Nov 14, 2024
pulisher
Nov 11, 2024

HC Wainwright Reaffirms Buy Rating for Entera Bio (NASDAQ:ENTX) - MarketBeat

Nov 11, 2024
pulisher
Nov 08, 2024

Entera Bio Ltd. (ENTX) Quarterly 10-Q Report - Quartzy

Nov 08, 2024
pulisher
Nov 08, 2024

Entera Bio Ltd. (ENTX) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 08, 2024
pulisher
Nov 08, 2024

Entera Bio Highlights Q3 2024 Financials and FDA Anticipation - TipRanks

Nov 08, 2024
pulisher
Nov 08, 2024

Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates - The Manila Times

Nov 08, 2024
pulisher
Oct 29, 2024

Short Interest in Entera Bio Ltd. (NASDAQ:ENTX) Drops By 14.4% - MarketBeat

Oct 29, 2024
pulisher
Oct 13, 2024

Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Up 38.4% in September - MarketBeat

Oct 13, 2024
pulisher
Oct 07, 2024

Entera Bio outlook steady as H.C. Wainwright backs potential of total hip BMD in osteoporosis care - Investing.com Australia

Oct 07, 2024
pulisher
Oct 07, 2024

Entera Bio (NASDAQ:ENTX) Rating Reiterated by HC Wainwright - MarketBeat

Oct 07, 2024
pulisher
Oct 04, 2024

Are Medical Stocks Lagging Argenx (ARGX) This Year? - Yahoo Finance

Oct 04, 2024
pulisher
Sep 30, 2024

ENTX & OPK Stock May Gain Following Positive PK/PD Research Data - MSN

Sep 30, 2024
pulisher
Sep 29, 2024

Entera Bio shares hold Buy rating on OXM study success By Investing.com - Investing.com Australia

Sep 29, 2024
pulisher
Sep 28, 2024

Entera Bio shares hold Buy rating on OXM study success - Investing.com

Sep 28, 2024
pulisher
Sep 27, 2024

Entera Bio's (ENTX) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Sep 27, 2024
pulisher
Sep 26, 2024

Entera Bio and OPKO Health report promising obesity treatment study By Investing.com - Investing.com Australia

Sep 26, 2024
pulisher
Sep 25, 2024

Entera Bio and OPKO Health report promising obesity treatment study - Investing.com

Sep 25, 2024
pulisher
Sep 25, 2024

Entera Bio And Opko Health Provide Update On Pk/Pd Results Of Oral Oxyntomodulin (Glp-1/Glucagon) Peptide Tablet Candidate For Obesity And Metabolic Disorders - XM

Sep 25, 2024
pulisher
Sep 25, 2024

Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide - EIN News

Sep 25, 2024
pulisher
Sep 20, 2024

Is Entera Bio (ENTX) Stock Outpacing Its Medical Peers This Year? - MSN

Sep 20, 2024
pulisher
Sep 03, 2024

Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year? - MSN

Sep 03, 2024
pulisher
Sep 01, 2024

Entera Bio Ltd. (NASDAQ:ENTX) Sees Significant Increase in Short Interest - MarketBeat

Sep 01, 2024
pulisher
Aug 30, 2024

We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate - Yahoo Finance

Aug 30, 2024
pulisher
Aug 20, 2024

Entera Bio to Participate in Upcoming Investor and Scientific Conferences - GlobeNewswire

Aug 20, 2024
pulisher
Aug 15, 2024

All You Need to Know About Entera Bio (ENTX) Rating Upgrade to Buy - Yahoo Finance

Aug 15, 2024
pulisher
Aug 15, 2024

Entera Bio Ltd. Forecasted to Earn Q3 2024 Earnings of ($0.05) Per Share (NASDAQ:ENTX) - Defense World

Aug 15, 2024
pulisher
Aug 15, 2024

Entera Bio Ltd. to Post Q3 2024 Earnings of ($0.05) Per Share, HC Wainwright Forecasts (NASDAQ:ENTX) - MarketBeat

Aug 15, 2024
pulisher
Aug 13, 2024

Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Down 51.0% in July - MarketBeat

Aug 13, 2024
pulisher
Aug 12, 2024

Entera Bio (NASDAQ:ENTX) Releases Earnings Results - MarketBeat

Aug 12, 2024
pulisher
Aug 12, 2024

Entera Bio's (ENTX) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Aug 12, 2024
pulisher
Aug 12, 2024

HC Wainwright Reiterates Buy Rating for Entera Bio (NASDAQ:ENTX) - Defense World

Aug 12, 2024
pulisher
Aug 09, 2024

Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates - GlobeNewswire

Aug 09, 2024
pulisher
Aug 09, 2024

Virtu Financial LLC Invests $37,000 in Entera Bio Ltd. (NASDAQ:ENTX) - Defense World

Aug 09, 2024
pulisher
Aug 07, 2024

Entera Bio Ltd expected to post a loss of 6 cents a shareEarnings Preview - XM

Aug 07, 2024
pulisher
Aug 06, 2024

The 10 Best Biotech Stocks Under $5 To Buy For September 2024! - The Stock Dork

Aug 06, 2024
pulisher
Aug 02, 2024

Entera Bio shareholders approve executive compensation, board appointments - Investing.com

Aug 02, 2024
pulisher
Aug 01, 2024

Entera’s EB613, the First Once Daily PTH(1-34) Tablet Treatment Dedicated to Post-Menopausal Women with High Risk Osteoporosis Abstract Selected for Presentation at the ASBMR 2024 Annual MeetingKey SABRE Update Also Expected - StockTitan

Aug 01, 2024
pulisher
Aug 01, 2024

Entera Bio (NASDAQ:ENTX) Trading Up 1.9% - MarketBeat

Aug 01, 2024
pulisher
Aug 01, 2024

Entera Bio (NASDAQ:ENTX) Stock Price Up 1.9% - Defense World

Aug 01, 2024
pulisher
Jul 28, 2024

Entera Bio (NASDAQ:ENTX) & Vericel (NASDAQ:VCEL) Financial Survey - Defense World

Jul 28, 2024
pulisher
Jul 27, 2024

Short bowel syndrome Market Positive Outlook: Phase Bio , Orphan Technologies , Zealand Pharma - Newstrail

Jul 27, 2024
pulisher
Jul 23, 2024

3 Meme Stocks to Buy and Hold for Potential 300% Returns in 3 Years - Markets Insider

Jul 23, 2024

Entera Bio Ltd (ENTX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Entera Bio Ltd 주식 (ENTX) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Taitel Haya
Director
Jan 10 '24
Buy
0.77
7,615
5,864
25,615
LIEBERMAN GERALD M
Director
Dec 22 '23
Buy
0.71
23,952
17,006
226,961
Toledano Miranda Jayne
Chief Executive Officer
Dec 22 '23
Buy
0.71
23,952
17,006
110,752
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
자본화:     |  볼륨(24시간):